Showing results (231-240 of 267) with videos related to
Sort By:
Pageof 27
British Journal of Clinical Pharmacology|June 3, 2015
The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patientsHagen Sjard Bachmann, Werner Meier, Andreas du Bois, et al.Journal of Neuro-Oncology|June 7, 2022
Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgeryAnna Michel, Thiemo Florin Dinger, Alejandro N Santos, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.Science (New York, N.Y.)|October 24, 2024
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesisJulia Phan, Brandon Chen, Zhiyu Zhao, et al.Cancers|March 25, 2022
Prediction of Short and Long Survival after Surgery for Breast Cancer Brain MetastasesAnna Michel, Marvin Darkwah Oppong, Laurèl Rauschenbach, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 23, 2016
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)Philipp Harter, Jalid Sehouli, Alexander Reuss, et al.World Neurosurgery|June 1, 2021
HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain MetastasesAnna Michel, Marvin Darkwah Oppong, Laurèl Rauschenbach, et al.Diagnostics (Basel, Switzerland)|January 10, 2026
Microsatellite Instability Status and Mismatch Repair Defects Testing in Endometrial Cancer-Insights from the Multicenter E-PEC TrialBüsra Eser, David Papior, Jon Salmanton-García, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup studyJens-Uwe Blohmer, Stefan Paepke, Jalid Sehouli, et al.Cancers|September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian CancerSabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.Pageof 27